Avita Medical | 売上総利益



Gross Profit On Sales 変化する 日付
Adcock Ingram Holdings ZAR 1.54B 73.26M 2024-12
Celltrion KRW 442.87B 100.93B 2025-03
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Cochlear AUD 881.7M 14.5M 2024-12
CSL USD 4.28B 939M 2024-12
Cspc Pharmaceutical CNY 4.71B 391.66M 2025-03
Dianthus Therapeutics 193K 970K 2025-06
Divis Laboratories Ltd 14.54B 1.5B 2025-06
Kangmei Pharma CNY 223.73M 38.54M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Malin Corporation EUR 3.8M 2.6M 2020-12
Mayne Pharma AUD 115.99M 63.1M 2024-06
Medical Developments International AUD 14.72M 1.36M 2024-12
Nanosonics AUD 73.44M 38.94M 2024-12
Organigram Holdings CAD 26.15M 25.1M 2025-06
Pacific Edge 283K 0 2024-03
Paradigm Biopharmaceuticals AUD 414.94K 4.82M 2024-12
Pharma Mar EUR 53.61M 18.15M 2025-06
Polynovo AUD 23.26M 22.74M 2024-06
PYC Therapeutics AUD 6.58M 2.13M 2024-06
Qiagen NV USD 334.29M 25.6M 2025-06
Ramsay Health Care AUD 6.32B 20.5M 2024-12
ResMed USD 829.44M 78.16M 2025-06
Sartorius EUR 416.2M 14.8M 2025-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Telix Pharmaceuticals AUD 129.12M 96.58M 2024-12
Tilray USD 61.22M 1.51M 2024-11
Zz Pientze Pharmaceu 296.13M 1.1B 2025-06


Avita Medical 売上総利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Sep 2025.